Y-H Chang
Overview
Explore the profile of Y-H Chang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
397
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
3.
Wang C, Lu Y, Hung W, Tsai I, Chang Y, Hu D, et al.
Public Health
. 2021 Jan;
190:135-144.
PMID: 33451823
Objectives: Diabetes mellitus is the most common cause of chronic kidney disease (CKD); however, the inter-relationships and pathogenetic mechanisms among risk factors are still largely unknown. Structural equation modelling (SEM)...
4.
Chang Y, Yokota H, Abe K, Tasi M, Chu S
J Microsc
. 2020 Jul;
281(1):57-75.
PMID: 32720710
Time-lapse confocal fluorescence microscopy images from mouse embryonic stem cells (ESCs) carrying reporter genes, histone H2B-mCherry and Mvh-Venus, have been used to monitor dynamic changes in cellular/differentiation characteristics of live...
5.
Tsai L, Cooper E, Hetzendorfer K, Warren G, Chang Y, Willett N
Osteoarthritis Cartilage
. 2019 Aug;
27(12):1851-1859.
PMID: 31437580
Objective: This study examined the effects of reduced and elevated weight bearing on post-traumatic osteoarthritis (PTOA) development, locomotor joint kinematics, and degree of voluntary activity in rats following medial meniscal...
6.
Phutanon N, Motina K, Chang Y, Ummartyotin S
Int J Biol Macromol
. 2019 Jun;
136:1142-1152.
PMID: 31247232
CuO was successfully prepared on bacterial cellulose paper as a nanocomposite using the forced hydrolysis technique. The composite paper presented outstanding photocatalytic and antibacterial properties. The effect of pH from...
7.
Bahrami N, Piccioni D, Karunamuni R, Chang Y, White N, Delfanti R, et al.
AJNR Am J Neuroradiol
. 2018 Apr;
39(6):1017-1024.
PMID: 29622553
Background And Purpose: Treatment with bevacizumab is standard of care for recurrent high-grade gliomas; however, monitoring response to treatment following bevacizumab remains a challenge. The purpose of this study was...
8.
Chang Y, Yin F, Fan G, Zhao M
Eur Rev Med Pharmacol Sci
. 2017 Oct;
21(18):4045-4049.
PMID: 29028098
Objective: miR-329-3p has been reported to serve as a tumor suppressor in the progression of cervical cancer (CC). The aim of this study was to investigate the clinical significance of...
9.
Decook L, Chang Y, Slack J, Gastineau D, Leis J, Noel P, et al.
Bone Marrow Transplant
. 2017 Apr;
52(7):998-1002.
PMID: 28436978
Comorbidities affect clinical outcomes and costs in medicine. The hematopoietic cell transplantation (HCT)-specific comorbidity index (HCT-CI) predicts mortality risk after HCT. Its association with resource utilization (RU) is unknown. In...
10.
Kim W, McNulty J, Chang Y, Weise M, Hashmi S, Ailawadhi S, et al.
Bone Marrow Transplant
. 2015 Jun;
50(9):1259-61.
PMID: 26030047
No abstract available.